83 related articles for article (PubMed ID: 8899431)
1. The effect of toremifene on the expression of genes in a rat mammary adenocarcinoma.
Kellen JA; Mirakian A
In Vivo; 1996; 10(5):511-3. PubMed ID: 8899431
[TBL] [Abstract][Full Text] [Related]
2. The effect of Toremifene on the expression of some genes in human mononuclear cells.
Kellen JA
In Vivo; 1995; 9(3):215-7. PubMed ID: 8562886
[TBL] [Abstract][Full Text] [Related]
3. Gene expression changes during the development of estrogen-independent and antiestrogen-resistant growth in breast cancer cell culture models.
Pennanen PT; Sarvilinna NS; Ylikomi TJ
Anticancer Drugs; 2009 Jan; 20(1):51-8. PubMed ID: 19343000
[TBL] [Abstract][Full Text] [Related]
4. Toremifene resistance in a rat mammary tumour model.
Kellen JA; Georges E; Ling V; Dubsky M
Anticancer Res; 1992; 12(5):1663-5. PubMed ID: 1359832
[TBL] [Abstract][Full Text] [Related]
5. Induction of apoptosis by iron depletion in the human breast cancer MCF-7 cell line and the 13762NF rat mammary adenocarcinoma in vivo.
Jiang XP; Wang F; Yang DC; Elliott RL; Head JF
Anticancer Res; 2002; 22(5):2685-92. PubMed ID: 12529982
[TBL] [Abstract][Full Text] [Related]
6. Tamoxifen-induced apoptosis in breast cancer cells relates to down-regulation of bcl-2, but not bax and bcl-X(L), without alteration of p53 protein levels.
Zhang GJ; Kimijima I; Onda M; Kanno M; Sato H; Watanabe T; Tsuchiya A; Abe R; Takenoshita S
Clin Cancer Res; 1999 Oct; 5(10):2971-7. PubMed ID: 10537367
[TBL] [Abstract][Full Text] [Related]
7. Altered gene expression profile in chemically induced rat mammary adenocarcinomas and its modulation by an aromatase inhibitor.
Wang Y; Hu L; Yao R; Wang M; Crist KA; Grubbs CJ; Johanning GL; Lubet RA; You M
Oncogene; 2001 Nov; 20(53):7710-21. PubMed ID: 11753649
[TBL] [Abstract][Full Text] [Related]
8. Dietary lutein inhibits mouse mammary tumor growth by regulating angiogenesis and apoptosis.
Chew BP; Brown CM; Park JS; Mixter PF
Anticancer Res; 2003; 23(4):3333-9. PubMed ID: 12926072
[TBL] [Abstract][Full Text] [Related]
9. Genomic effects of tamoxifen.
Kellen JA
Anticancer Res; 1996; 16(6B):3537-41. PubMed ID: 9042218
[TBL] [Abstract][Full Text] [Related]
10. A comparative study of the effect of raloxifene and gosereline on uterine leiomyoma volume changes and estrogen receptor, progesterone receptor, bcl-2 and p53 expression immunohistochemically in premenopausal women.
Baytur YB; Ozbilgin K; Cilaker S; Lacin S; Kurtul O; Oruc S; Koyuncu FM
Eur J Obstet Gynecol Reprod Biol; 2007 Nov; 135(1):94-103. PubMed ID: 16973256
[TBL] [Abstract][Full Text] [Related]
11. Bcl-2/Bax protein ratio predicts 5-fluorouracil sensitivity independently of p53 status.
Mirjolet JF; Barberi-Heyob M; Didelot C; Peyrat JP; Abecassis J; Millon R; Merlin JL
Br J Cancer; 2000 Nov; 83(10):1380-6. PubMed ID: 11044365
[TBL] [Abstract][Full Text] [Related]
12. WAP-TAg transgenic mice and the study of dysregulated cell survival, proliferation, and mutation during breast carcinogenesis.
Li M; Lewis B; Capuco AV; Laucirica R; Furth PA
Oncogene; 2000 Feb; 19(8):1010-9. PubMed ID: 10713684
[TBL] [Abstract][Full Text] [Related]
13. The prognostic significance of p53 and bcl-2 expression in lung adenocarcinoma and its correlation with Ki-67 growth fraction.
Ishida H; Irie K; Itoh T; Furukawa T; Tokunaga O
Cancer; 1997 Sep; 80(6):1034-45. PubMed ID: 9305703
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical determination of P-glycoprotein in a rat mammary tumour treated with tamoxifen.
Kellen JA; Wong AC; Mirakian A
In Vivo; 1992; 6(5):541-4. PubMed ID: 1360843
[TBL] [Abstract][Full Text] [Related]
15. Effects of estradiol on the expression and production of IGFBP-2 by R3230AC mammary tumor cells.
Korc-Grodzicki B; Ren N; Hilf R
Oncol Res; 1996; 8(12):473-83. PubMed ID: 9160351
[TBL] [Abstract][Full Text] [Related]
16. [Expressions of hTERT, p53, c-erbB-2 and Bcl-2 in colonic adenocarcinoma mouse models with liver metastases: effects of classical traditional Chinese medicine prescriptions for promoting circulation and removing blood stasis].
Wang C; Yang YG; Wang XL
Di Yi Jun Yi Da Xue Xue Bao; 2004 Jul; 24(7):758-60. PubMed ID: 15257895
[TBL] [Abstract][Full Text] [Related]
17. Toremifene prevents prostate cancer in the transgenic adenocarcinoma of mouse prostate model.
Raghow S; Hooshdaran MZ; Katiyar S; Steiner MS
Cancer Res; 2002 Mar; 62(5):1370-6. PubMed ID: 11888907
[TBL] [Abstract][Full Text] [Related]
18. Correlation between the expression of apoptosis-related bcl-2 and p53 oncoproteins and the carcinogenesis and progression of breast carcinomas.
Zhang GJ; Kimijima I; Abe R; Kanno M; Katagata N; Hara K; Watanabe T; Tsuchiya A
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2329-35. PubMed ID: 9815631
[TBL] [Abstract][Full Text] [Related]
19. Regulators of proliferation and apoptosis in carcinoma of the larynx.
Whisler LC; Wood NB; Caldarelli DD; Hutchinson JC; Panje WR; Friedman M; Preisler HD; Leurgans S; Nowak J; Coon JS
Laryngoscope; 1998 May; 108(5):630-8. PubMed ID: 9591537
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical study of apoptosis-related Bcl-2 protein and its correlation with proliferation indices (Ki67, PCNA), tumor suppressor genes (p53, pRb), the oncogene c-erbB-2, sex steroid hormone receptors and other clinicopathological features, in normal, hyperplastic and neoplastic endometrium.
Mitselou A; Ioachim E; Kitsou E; Vougiouklakis T; Zagorianakou N; Makrydimas G; Stefanaki S; Agnantis NJ
In Vivo; 2003; 17(5):469-77. PubMed ID: 14598611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
